JPRN-UMIN000028634尚未招募未知
Multicenter trial of effects for glucometabolism, platelet activation marker and inflammatory marker by single or combinathin therapy with tofogliflozin and anagliptin in type 2 diabetic patients - Kansai - Collaborative Anti-atherothrombotic Medicine study group
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. type 1 diabetes or secondary diabetes 2. contraindication for medicine 3. allergy 4. eGFR < 30mL/min/1.73m2 5. AST or ALT > 120IU/L 6. history of appoplexy 7. pregnancy or lactationperiod 8. urinary infection, social disease 9. malignancy 10. inappropriate patients
研究者
相似试验
招募中
4 期
A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp®) in comparison to insulin aspart (NovoRapid®) around exercise in participants with type 1 diabetesE10Type 1 diabetes mellitusDRKS00015855Forschungseinheit für interdisziplinäre metabolische Medizin, Medizinische Universität Graz44
进行中（未招募）
1 期
A study that investigates the effects of fast-acting insulin (FIASP®) on blood sugars in comparison to a different fast-acting insulin (NovoRapid®) around exercise in participants with type 1 diabetesMedDRA version: 20.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861Type 1 DiabetesEUCTR2019-001281-14-ATMedical University of Graz44
已完成
2 期
Study of the glucose metabolism-improving effect of the 12-week intake of beverages containing lactic acid bacteriaHyperglycemiaJPRN-UMIN000023466HUMA R&D CORP130
已完成
2 期
Study of the glucose metabolism-improving effect of the 12-week intake of food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group studyHyperglycemiaJPRN-UMIN000032837KSO Corporation130
已完成
不适用
Study of the glucose metabolism-improving effect of the 12-week intake of test food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group studyHyperglycemiaJPRN-UMIN000047804KSO Corporation148